Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts-Reference-Cited by-同舟云学术

Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts

Published:2015-03-23 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Tsukihara Hiroshi¹,Nakagawa Fumio²,Sakamoto Kazuki³,Ishida Keiji³,Tanaka Nozomu³,Okabe Hiroyuki³,Uchida Junji²,Matsuo Kenichi³,Takechi Teiji¹

Affiliation:

1. Translational Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd., Kawauchi-Cho, Tokushima-shi, Tokushima 771-0194, Japan

2. Applied Pharmacology Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd., Kawauchi-Cho, Tokushima-shi, Tokushima 771-0194, Japan

3. Tsukuba Research Center, Taiho Pharmaceutical Co., Ltd., Okubo, Tsukuba, Ibaraki 300-2611, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSMA-targeted combination brusatol and docetaxel nanotherapeutics for the treatment of prostate cancer;Biomedicine & Pharmacotherapy;2024-08

2. DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells;EMBO Molecular Medicine;2024-07-15

3. Innovations in colorectal cancer treatment: trifluridine and tipiracil with bevacizumab for improved outcomes – a review;Frontiers in Oncology;2024-07-12

4. Phase I study of trifluridine/tipiracil (TAS-102) plus irinotecan in combination with bevacizumab as a second-line therapy for patients with metastatic colorectal cancer;Investigational New Drugs;2024-07-11

5. Efficacy and safety of trifluridine/tipiracil plus bevacizumab across different subgroups of patients with refractory colorectal cancer: a meta-analysis;ecancermedicalscience;2024-07-10